Outcomes of Planned 2-Stage Hybrid Aortic Repair with Dacron Replaced Proximal Landing Zone.
CONCLUSIONS: Planned 2-stage HAR with open 1st stage PAR followed by 2nd stage TEVAR with Dacron replaced PLZ yields excellent short and long-term results, including low rates of re-intervention likely due to long-segment PLZ within Dacron-replaced aorta. The technique should be considered in patients with even mild (>4.0 cm) ascending aortic dilation in whom HAR is otherwise the preferred treatment option. PMID: 29775605 [PubMed - as supplied by publisher]
ConclusionsSeptal myectomy, performed in a tertiary referral center, had a 30-day mortality rate of 0% and low morbidity rate. There was no difference between observed myectomy mortality and STS Calculator predicted risk for AVR and MV repair. It is possible that a larger sample could reveal lower mortality than STS prediction.
CONCLUSION: Valve replacement in patients with hugely dilated left ventricle are safe operations with satisfactory outcomes even if combined with other procedures, especially with proper preoperative preparation, intraoperative preservation of posterior mitral leaflet, and meticulous postoperative follow up in the surgical ICU. PMID: 31895029 [PubMed - in process]
Publication date: Available online 23 October 2019Source: The Annals of Thoracic SurgeryAuthor(s): Vinod H. Thourani, John J. Kelly, David Cervantes, Sreekanth Vemulapalli, Pratik Manandhar, Jessica Forcillo, David Holmes, David J. Cohen, Ajay Kirtane, Susheel Kodali, Martin Leon, Vasilis Babaliaros, Ron Waksman, Lowell Satler, Christian Shults, Itsik Ben-Dor, Toby Rogers, Samir Kapadia, Micheal Reardon, S. Chris MalaisrieAbstractBackgroundDue to perceived technical challenges, patients with previous surgical mitral valve repair or replacement (SMVR) have been excluded from most transcatheter aortic valve replacement (TAVR...
varia JE, Herrmann H, Szeto WY, Carroll JD, Mack M Abstract BACKGROUND: Due to perceived technical challenges, patients with previous surgical mitral valve repair or replacement (SMVR) have been excluded from most transcatheter aortic valve replacement (TAVR) trials. Our objective was to compare the 30-day and 1-year outcomes of TAVR in patients with and without prior SMVR. METHODS: In a retrospective review of the Society of Thoracic Surgeons (STS) and American College of Cardiology (ACC) Transcatheter Valve Therapy (TVT) Registry, we compared 1,097 patients with prior SMVR to 46,327 without prior SMVR who u...
ConclusionsIn the current era with careful patient selection and periprocedural management, isolated TV surgery can be performed with lower morbidity and mortality than has traditionally been reported with good long term survival. These outcomes can also serve as a benchmark for catheter-based tricuspid valve intervention outcomes.
CONCLUSIONS: In the current era with careful patient selection and periprocedural management, isolated TV surgery can be performed with lower morbidity and mortality than has traditionally been reported with good long term survival. These outcomes can also serve as a benchmark for catheter-based tricuspid valve intervention outcomes. PMID: 30951698 [PubMed - as supplied by publisher]
ConclusionsPlanned two-stage HAR with open first-stage proximal aortic replacement, followed by second-stage TEVAR with Dacron-replaced PLZ yields excellent short-term and long-term results, including low rates of reintervention likely due to the long-segment PLZ within the Dacron-replaced aorta. The technique should be considered in patients with even mild (>4.0 cm) ascending aortic dilation in whom HAR is otherwise the preferred treatment option.
Publication date: July 2018Source: The Annals of Thoracic Surgery, Volume 106, Issue 1Author(s): Damien J. LaPar, Donald S. Likosky, Min Zhang, Patty Theurer, C. Edwin Fonner, John A. Kern, Steven F. Bolling, Daniel H. Drake, Alan M. Speir, Jeffrey B. Rich, Irving L. Kron, Richard L. Prager, Gorav Ailawadi, Investigators for the Virginia Cardiac Surgery Quality Initiative and the Michigan Society of Thoracic and Cardiovascular SurgeonsBackgroundAlthough tricuspid valve operations remain associated with high mortality (approximately 8% to 10%), no robust prediction models exist to support clinical decision making. We develo...
Conclusion: Many patients with major vascular complications during TAVI can be treated with a pure endovascular approach. In our small series we observed no difference in concurrent complications when an endovascular repair can be rapidly initiated as compared to a primary surgical approach.
CONCLUSION: These data are the first from the U.K. demonstrating early and late outcomes after thoracoscopic assisted minimally invasive mitral valve repair surgery. The data establish the safety and efficacy of the technique and, importantly, lend further support towards a prospective randomized comparison of minimally invasive versus conventional mitral valve repair surgery. PMID: 26897819 [PubMed - in process]